Omeprazole sodium for injection by generic drug quality and efficacy consistency evaluation


Time:

2022-09-19

On September 9, 2022, omeprazole sodium for injection, the main product of our freeze-dried preparation, was approved by the State Drug Administration and passed the quality and efficacy consistency evaluation of generic drugs.

Omeprazole Sodium for Injection is mainly used for: ① peptic ulcer bleeding and anastomotic ulcer bleeding; ② Acute gastric mucosal damage complicated by stress state and acute gastric mucosal damage caused by non-steroidal anti-inflammatory drugs; ③ Prevention of stress state of severe diseases (such as cerebral hemorrhage, severe trauma, etc.) and upper gastrointestinal bleeding caused by gastric surgery; ④ As an alternative therapy for the following diseases when oral therapy is not applicable: duodenal ulcer, gastric ulcer, reflux esophagitis and Zollinger-Ellison syndrome.

The drug passed the consistency evaluation, which is the embodiment of the company's comprehensive strength in R & D, production and quality management system, and is also the recognition of our R & D, production capacity and product quality by the national drug regulatory department.

Author: Jiang Shiqi